APA
Casali P. G., Le Cesne A., Poveda Velasco A., Kotasek D., Rutkowski P., Hohenberger P., Fumagalli E., Judson I. R., Italiano A., Gelderblom H., Adenis A., Hartmann J. T., Duffaud F., Goldstein D., Broto J. M., Gronchi A., Dei Tos A. P., Marréaud S., van der Graaf W. T. A., Zalcberg J. R., Litière S. & Blay J. (20160428). Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Casali Paolo G, Le Cesne Axel, Poveda Velasco Andres, Kotasek Dusan, Rutkowski Piotr, Hohenberger Peter, Fumagalli Elena, Judson Ian R, Italiano Antoine, Gelderblom Hans, Adenis Antoine, Hartmann Jörg T, Duffaud Florence, Goldstein David, Broto Javier M, Gronchi Alessandro, Dei Tos Angelo P, Marréaud Sandrine, van der Graaf Winette T A, Zalcberg John R, Litière Saskia and Blay Jean-Yves. 20160428. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Casali P. G., Le Cesne A., Poveda Velasco A., Kotasek D., Rutkowski P., Hohenberger P., Fumagalli E., Judson I. R., Italiano A., Gelderblom H., Adenis A., Hartmann J. T., Duffaud F., Goldstein D., Broto J. M., Gronchi A., Dei Tos A. P., Marréaud S., van der Graaf W. T. A., Zalcberg J. R., Litière S. and Blay J. (20160428). Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Casali Paolo G, Le Cesne Axel, Poveda Velasco Andres, Kotasek Dusan, Rutkowski Piotr, Hohenberger Peter, Fumagalli Elena, Judson Ian R, Italiano Antoine, Gelderblom Hans, Adenis Antoine, Hartmann Jörg T, Duffaud Florence, Goldstein David, Broto Javier M, Gronchi Alessandro, Dei Tos Angelo P, Marréaud Sandrine, van der Graaf Winette T A, Zalcberg John R, Litière Saskia and Blay Jean-Yves. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20160428.